David Hickey - Nov 26, 2022 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Role
EVP & President, Life Sciences
Signature
Donna Kalazdy, by power of attorney for David Hickey
Stock symbol
BDX
Transactions as of
Nov 26, 2022
Transactions value $
$0
Form type
4
Date filed
11/29/2022, 04:24 PM
Previous filing
Aug 17, 2022
Next filing
Aug 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDX Common Stock Award $0 +1.82K +54.52% $0.00 5.15K Nov 26, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDX Stock Appreciation Rights Award $0 +11K $0.00 11K Nov 26, 2022 Common Stock 11K $238.06 Direct F2
transaction BDX Rights to Common Stock Under Deferred Compensation Plan Award $0 +1.13K +10.25% $0.00 12.1K Nov 26, 2022 Common Stock 1.13K $238.06 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2 The stock appreciation rights vest in four annual installments beginning November 26, 2023.
F3 The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person